- Home
- ARWR vs ACT Comparison
ARWR vs ACT Comparison
Compare ARWR & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ACT
- Stock Information
- Founded
- ARWR 2003
- ACT 1981
- Country
- ARWR United States
- ACT United States
- Employees
- ARWR N/A
- ACT N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ACT Specialty Insurers
- Sector
- ARWR Health Care
- ACT Finance
- Exchange
- ARWR Nasdaq
- ACT Nasdaq
- Market Cap
- ARWR 5.9B
- ACT 5.5B
- IPO Year
- ARWR 1993
- ACT 2021
- Fundamental
- Price
- ARWR $40.96
- ACT $37.64
- Analyst Decision
- ARWR Strong Buy
- ACT Hold
- Analyst Count
- ARWR 8
- ACT 3
- Target Price
- ARWR $47.75
- ACT $39.67
- AVG Volume (30 Days)
- ARWR 1.7M
- ACT 284.1K
- Earning Date
- ARWR 11-25-2025
- ACT 11-05-2025
- Dividend Yield
- ARWR N/A
- ACT 2.23%
- EPS Growth
- ARWR N/A
- ACT 1.64
- EPS
- ARWR N/A
- ACT 4.36
- Revenue
- ARWR $572,976,000.00
- ACT $1,224,897,000.00
- Revenue This Year
- ARWR $21,287.22
- ACT $4.35
- Revenue Next Year
- ARWR N/A
- ACT $3.75
- P/E Ratio
- ARWR N/A
- ACT $8.63
- Revenue Growth
- ARWR 2816.20
- ACT 2.40
- 52 Week Low
- ARWR $9.57
- ACT $30.79
- 52 Week High
- ARWR $43.69
- ACT $39.47
- Technical
- Relative Strength Index (RSI)
- ARWR 60.87
- ACT 60.99
- Support Level
- ARWR $37.35
- ACT $35.85
- Resistance Level
- ARWR $42.00
- ACT $37.47
- Average True Range (ATR)
- ARWR 2.18
- ACT 0.80
- MACD
- ARWR -0.28
- ACT 0.27
- Stochastic Oscillator
- ARWR 61.35
- ACT 94.10
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.